
Nano-X Imaging (NNOX) Stock Forecast & Price Target
Nano-X Imaging (NNOX) Analyst Ratings
Bulls say
Nano X Imaging Ltd has demonstrated solid financial performance with a quarterly revenue increase to $3.4 million, attributed to enhanced teleradiology utilization and improved operational margins. The company's strategic initiatives, including a successful partnership with Monarch and a new reseller agreement with 3DR Labs for AI imaging solutions, signify potential for accelerated market adoption and broader commercialization. Additionally, the reaffirmation of its 2026 revenue guidance of $35 million indicates strong confidence in future growth driven by increased unit placements and diverse revenue channels.
Bears say
Nano X Imaging Ltd has reported a decline in cash reserves, decreasing from $83.2 million to $55.5 million, primarily due to a significant operating cash burn of $30.4 million and limited at-the-market (ATM) usage. The company's revenue growth expectations have been consistently lowered over the past year, indicating challenges in generating anticipated income. Additionally, the GAAP gross loss remains high at $2.9 million, alongside a stable net loss of $13.7 million, highlighting ongoing investment burdens and a lack of profitability in its operational segments.
This aggregate rating is based on analysts' research of Nano-X Imaging and is not a guaranteed prediction by Public.com or investment advice.
Nano-X Imaging (NNOX) Analyst Forecast & Price Prediction
Start investing in Nano-X Imaging (NNOX)
Order type
Buy in
Order amount
Est. shares
0 shares